Causes of Prolonged PTT (aPTT)
A prolonged activated partial thromboplastin time (aPTT) with normal PT/INR results from three main categories: anticoagulant drugs (most common), lupus anticoagulant/antiphospholipid antibodies, or intrinsic/common pathway coagulation factor deficiencies.
Primary Causes
1. Anticoagulant Medications (Most Common)
- Unfractionated heparin (UFH): aPTT is highly sensitive and correlates with heparin concentration 1, 2
- Direct thrombin inhibitors (dabigatran): Highly sensitive, prolongs aPTT significantly 1, 3
- Low molecular weight heparins (LMWH): Can prolong aPTT, particularly tinzaparin which has greater anti-IIa activity 1, 4
- Direct factor Xa inhibitors: Inconsistently prolong aPTT (apixaban, rivaroxaban, edoxaban) 1
Critical pitfall: Always exclude anticoagulant drugs first—this accounts for approximately 75% of isolated prolonged aPTT cases when combined with factor XII abnormalities 5, 6.
2. Lupus Anticoagulant (LA) / Antiphospholipid Antibodies
- Most common non-drug cause of isolated prolonged aPTT 7, 6
- Paradoxically associated with thrombosis risk, not bleeding 8, 9
- aPTT may be prolonged in COVID-19 patients due to lupus anticoagulants (reported in 20-45% of cases) 8
- Does not correct with 50:50 mixing studies 10
3. Coagulation Factor Deficiencies (Intrinsic/Common Pathway)
Intrinsic pathway factors:
- Factor VIII deficiency: Hemophilia A (congenital or acquired) 11, 5
- Factor IX deficiency: Hemophilia B
- Factor XI deficiency: Mild bleeding tendency
- Factor XII deficiency: Most common factor deficiency causing isolated prolonged aPTT but no bleeding risk 5, 7
Common pathway factors:
- Factor X deficiency: Prolongs both PT and aPTT, but aPTT may be more sensitive 10
- Factor V deficiency: Rare
- Factor II (prothrombin) deficiency: Rare
- Fibrinogen deficiency: Usually prolongs PT more than aPTT 12
Key distinction: Factor deficiencies correct with 50:50 mixing studies (except when inhibitors present), while lupus anticoagulant does not 10, 6.
4. Acquired Factor Inhibitors
- Acquired hemophilia A: Anti-factor VIII antibodies, rare but life-threatening with significant bleeding 11, 5
- Mixing studies show incomplete or no correction 9
- Requires urgent recognition—laboratory algorithms can identify on day 1 of hospitalization 5
5. Pre-analytical Issues and Artifacts
- Heparin contamination: From IV lines or collection tubes 9
- Underfill of citrate tubes: Excess citrate causes spurious prolongation
- Sample processing errors: Delayed processing, improper centrifugation 10
- Laboratory artifact: Accounts for 5% of cases 7
Diagnostic Algorithm
Step 1: Exclude anticoagulant drugs
- Measure anti-Xa activity (UFH/LMWH calibration) 1
- Thrombin time (TT) for UFH and dabigatran 1
- DOAC-specific assays if suspected 1
Step 2: Perform 50:50 mixing study
- Corrects to normal: Factor deficiency likely
- Does not correct: Lupus anticoagulant or specific factor inhibitor 6, 9
Step 3: If mixing study corrects
- Measure factor VIII, IX, XI, XII levels 6
- Factor XII deficiency is most common but clinically benign 5
Step 4: If mixing study does not correct
- Lupus anticoagulant testing: Dilute Russell's viper venom time (dRVVT), Actin FS-aPTT 9
- Specific factor inhibitor assays: Bethesda assay for factor VIII inhibitor if bleeding present 11
Step 5: Consider additional causes
- Liver disease (usually affects PT more)
- Vitamin K deficiency (affects PT primarily)
- Consumptive coagulopathy in critically ill patients 8
- Antithrombin deficiency (heparin resistance) 8
Clinical Context Matters
With bleeding symptoms: Prioritize factor deficiencies and acquired inhibitors (especially acquired hemophilia A) 11, 5
Without bleeding symptoms: Lupus anticoagulant, factor XII deficiency, or laboratory artifact most likely 7, 6
In COVID-19 patients: High prevalence of lupus anticoagulants (up to 45%), acute phase reactants may cause heparin resistance 8
Pre-operative setting: Urgent evaluation required—postpone surgery until cause identified, especially if bleeding history present 9
Important Caveats
- aPTT sensitivity varies significantly between reagents—different thromboplastins show considerable variability 10, 13
- Acute phase reactants (elevated fibrinogen, CRP) can interfere with aPTT and cause heparin resistance 8
- Normal aPTT does not exclude all anticoagulants—LMWH and fondaparinux poorly detected 1
- Isolated prolonged aPTT with normal PT occurs in approximately 0.5% of routine samples 5